-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DKiaNMsHe9jYvzKtE+gf6tL8BnPp+zPXjQR84SbQigGOSr8oSFzDNL/rNkxNMHLX Q2E8suWAf7f4zUW0e7vDVw== 0000769993-99-000042.txt : 19990112 0000769993-99-000042.hdr.sgml : 19990112 ACCESSION NUMBER: 0000769993-99-000042 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19981231 FILED AS OF DATE: 19990111 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CORAM HEALTHCARE CORP CENTRAL INDEX KEY: 0000924174 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 330615337 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: SEC FILE NUMBER: 001-11343 FILM NUMBER: 99504316 BUSINESS ADDRESS: STREET 1: 1125 SEVENTEENTH ST STE 1500 CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 3032924973 MAIL ADDRESS: STREET 1: ONE LAKESHORE CENTRE STREET 2: 3281 GUASTI ROAD SUITE 700 CITY: ONTARIO STATE: CA ZIP: 91761 COMPANY DATA: COMPANY CONFORMED NAME: GOLDMAN SACHS GROUP LP CENTRAL INDEX KEY: 0000904571 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] OWNER IRS NUMBER: 133501777 STATE OF INCORPORATION: NY FISCAL YEAR END: 1130 FILING VALUES: FORM TYPE: 4 BUSINESS ADDRESS: STREET 1: 85 BROAD ST CITY: NEW YORK STATE: NY ZIP: 10004 BUSINESS PHONE: 2129021000 MAIL ADDRESS: STREET 1: 85 BROAD STREET CITY: NEW YORK STATE: NY ZIP: 10004 4 1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). ================================================================================ 1. Name and Address of Reporting Person* The Goldman Sachs Group, L.P. - -------------------------------------------------------------------------------- (Last) (First) (Middle) 85 Broad Street - -------------------------------------------------------------------------------- (Street) New York, NY 10004 - -------------------------------------------------------------------------------- (City) (State) (Zip) ================================================================================ 2. Issuer Name and Ticker or Trading Symbol Coram Healthcare Corporation (CRH) ================================================================================ 3. I.R.S. Identification Number of Reporting Person, if an entity (voluntary) ================================================================================ 4. Statement for Month/Year December/1998 ================================================================================ 5. If Amendment, Date of Original (Month/Year) ================================================================================ 6. Relationship of Reporting Person(s) to Issuer (Check all applicable) [ ] Director [ X ] 10% Owner [ ] Officer (give title below) [ ] Other (specify below) ------------------------------------------- ================================================================================ 7. Individual or Joint/Group Filing (Check Applicable Line) [ ] Form filed by One Reporting Person [ X ] Form filed by More than One Reporting Person ================================================================================
==================================================================================================================================== Table I -- Non-Derivative Securities Acquired, Disposed of, | or Beneficially Owned | ==================================================================================================================================== | | | | |6. | | | | | 4. |5. |Owner- | | | | | Securities Acquired (A) or |Amount of |ship | | | | 3. | Disposed of (D) |Securities |Form: |7. | | | Transaction| (Instr. 3, 4 and 5) |Beneficially |Direct |Nature of | |2. | Code | -------------------------------|Owned at End |(D) or |Indirect | 1. |Transaction | (Instr. 8) | | (A) | |of Month |Indirect |Beneficial| Title of Security |Date | -----------| Amount | or | Price |(Instr. 3 |(I) |Ownership | (Instr. 3) |(mm/dd/yy) | Code | V | | (D) | |and 4) |(Instr.4)|(Instr. 4)| - -----------------------------------------------------------------------------------------------------------------------------------| | | | | | | | | | | | | | | | | | | | | - -----------------------------------------------------------------------------------------------------------------------------------| | | | | | | | | | | | | | | | | | | | | ====================================================================================================================================
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4(b)(v). FORM 4 (continued)
==================================================================================================================================== Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned | (e.g., puts, calls, warrants, options, convertible securities) | ==================================================================================================================================== | | | | | | | |9. |10. | | | | | | | | | |Number |Owner-| | | | | | | | | |of |ship | | |2. | | | | | | |Deriv- |of | | |Conver- | | | 5. | |7. | |ative |Deriv-|11. | |sion | | | Number of | |Title and Amount | |Secur- |ative |Nature| |or | | | Derivative |6. |of Underlying |8. |ities |Secur-|of | |Exer- | |4. | Securities |Date |Securities |Price |Bene- |ity: |In- | |cise |3. |Trans- | Acquired (A) |Exercisable and |(Instr. 3 and 4) |of |ficially|Direct|direct| |Price |Trans- |action | or Disposed |Expiration Date |------------------------|Deriv- |Owned |(D) or|Bene- | 1. |of |action |Code | of (D) |(Month/Day/Year) | |Amount |ative |at End |In- |ficial| Title of |Deriv- |Date |(Instr | (Instr. 3, |-----------------| |or |Secur- |of |direct|Owner-| Derivative |ative |(Month/ |8) | 4 and 5) |Date |Expira- | |Number |ity |Month |(I) |ship | Security |Secur- |Day/ |------ | ------------ |Exer- |tion | |of |(Instr. |(Instr. |(Instr|(Instr| (Instr. 3) |ity |Year) |Code |V| (A) | (D) |cisable |Date |Title |Shares |5) |4) |4) |4) | - -----------------------------------------------------------------------------------------------------------------------------------| Common Stock | | | | | | | | | | | | | | | Warrants | | | | | | | | | | | | | | | (right to buy) |$22.125 |12/21/98| P | | 249 | | Immed. |07/11/99|Common Stock | 249| $.0004 | 249 | 01 | 01 | - -----------------------------------------------------------------------------------------------------------------------------------| Series B | | | | | | | | | | | | | | | Convertible | | | | | | | | | | | | | | | Subordinated | | | | | | | | | | | | | | | Notes | $3.00 | | | | | | Immed. |04/15/08|Common Stock |13,320,844| | 02 | 02 | 02 | - -----------------------------------------------------------------------------------------------------------------------------------| Common Stock | | | | | | | | | | | | | | | Warrants | | | | | | | | | | | | | | | (right to buy) | $.001 | | | | | | Immed. |10/13/00|Common Stock | 178,427| | 02 | 02 | 02 | - -----------------------------------------------------------------------------------------------------------------------------------| Common Stock | | | | | | | | | | | | | | | Warrants (03) | | | | | | | | | | | | | | | (right to buy) | $.001 | | | | | | Immed. | 03 |Common Stock | 863,588| |02 & 03 |02&03 |02&03 | - -----------------------------------------------------------------------------------------------------------------------------------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ====================================================================================================================================
Instruction 4(b)(v) list of other Reporting Persons: This statement is being filed by Goldman Sachs Credit Partners, L.P. ("GS Credit Partners"), Goldman Sachs Global Holdings L.L.C. ("GS Global Holdings"), The Goldman Sachs Group, L.P. ("GS Group") and Goldman, Sachs & Co. ("Goldman Sachs", and together with GS Credit Partners, GS Global Holdings and GS Group, the "Reporting Persons"). The principal business address of each of GS Global Holdings, GS Group and Goldman Sachs is 85 Broad Street, New York, New York 10004. The principal business address of GS Credit Partners is Conyers, Dill & Pearman, Church Street, Hamilton HM CX, Bermuda. Explanation of Responses: 01: On December 21, 1998, Goldman Sachs acquired warrants giving Goldman Sachs the right to acquire 249 shares of Common Stock of Coram Healthcare Corporation (the "Company"). These warrants may be deemed to be beneficially owned directly by Goldman Sachs and may be deemed to be beneficially owned indirectly by GS Group. Without admitting any legal obligation, Goldman Sachs will remit appropriate profits, if any, to the Company. GS Group disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein. 02: Goldman Sachs, GS Group and GS Global Holdings may be deemed to own beneficially and indirectly in the aggregate 13,320,844 shares of Common Stock by reason of the ownership by GS Credit Partners of (a) $30,970,375.22 principal amount of Series B convertible Subordinated Notes of the Company due 2008 ("Convertible Notes") issued pursuant to the Securities Exchange Agreement dated May 6, 1998 (the "Securities Exchange Agreement") which are convertible into 10,323,458 shares of Common Stock and (b) $8,992,158.80 principal amount of Convertible Notes issued pursuant to the Securities Exchange Agreement and held subject to a risk participation agreement ("Risk Participation Notes") which are convertible into 2,997,386 shares of Common Stock. GS Credit Partners and certain other parties (collectively the "Noteholders") entered into the Securities Exchange Agreement with the Company and Coram, Inc. GS Group is the 99% owner of GS Global Holdings. GS Global Holdings is the general partner of GS Credit Partners. GS Group is the general partner of and owns a 99% interest in Goldman Sachs. Goldman Sachs, GS Group and GS Global Holdings each disclaim beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein. GS Credit Partners may be deemed to own beneficially and directly $30,970,375.22 principal amount of Convertible Notes issued pursuant to the Securities Exchange Agreement which are convertible into 10,323,458 shares of Common Stock and beneficially and indirectly $8,992,158.80 principal amount of Risk Participation Notes which are convertible into 2,997,386 shares of Common Stock. Goldman Sachs may be deemed to own beneficially and directly and GS Group may be deemed to own beneficially and indirectly warrants to purchase 178,427 shares of Common Stock of the Company and New Warrants (as defined below) to purchase 863,588 shares of Common Stock of the Company. GS Group disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein. 03: Goldman Sachs may be deemed to own beneficially and directly warrants to purchase 863,588 shares (subject to antidilution and other adjustments) of Common Stock of the Company (the "New Warrants"). The New Warrants were issued pursuant to the warrant agreement dated as of August 26, 1998 to which GS Credit Partners and the Company were party (the "New Warrant Agreement") in connection with the senior loan agreement dated as of August 20, 1998 to which GS Credit Partners and the Company were party (the "Senior Loan Agreement"). The New Warrants are exercisable on or before the earlier to occur of (i) thirty months from the closing date of the Senior Loan Agreement and (ii) such earlier date on which the revolving credit commitments of the Senior Loan Agreement terminate at an exercise price equal to the par value of such New Warrant Share (i.e., $0.001 per share). Signatures: THE GOLDMAN SACHS GROUP, L.P By: s/ Hans L. Reich ---------------------------- Name: Hans L. Reich Title: Attorney-in-fact GOLDMAN, SACHS & CO. By: s/ Hans L. Reich ---------------------------- Name: Hans L. Reich Title: Attorney-in-fact GOLDMAN SACHS CREDIT PARTNERS, L.P. By: s/ Hans L. Reich ---------------------------- Name: Hans L. Reich Title: Attorney-in-fact GOLDMAN SACHS GLOBAL HOLDINGS L.L.C By: s/ Hans L. Reich ---------------------------- Name: Hans L. Reich Title: Attorney-in-fact Date: January 11, 1999 ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space provided is insufficient, see Instruction 6 for procedures. Alternatively, this Form is permitted to be submitted to the Commission in electronic format at the option of the reporting person pursuant to Rule 101(b)(4) of Regulation S-T.
-----END PRIVACY-ENHANCED MESSAGE-----